Medscape Medical News - FDA Approvals
- Alert FDA Clears Dexcom G7 CGM for 15-Day Wear
- Alert FDA Approves Nivolumab + Ipilimumab for Certain CRC Patients
- Alert FDA Approves First and Only Therapy for IgG4-RD
- Alert FDA Okays Perioperative Durvalumab for Bladder Cancer
- Alert FDA Okays Pluvicto for Earlier Use in Prostate Cancer
- Alert Fitusiran Approved for Hemophilia A, B
- Alert FDA Approves Fourth Denosumab Biosimilar
- Alert FDA OKs Cabozantinib for Pancreatic Neuroendocrine Tumors
- Alert FDA OKs Guselkumab for Crohn’s Disease
- Alert FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy
- Alert FDA Approves First Biosimilar to Omalizumab
- Alert Tislelizumab Approved for First-Line in ESCC
- Alert FDA Okays Tenecteplase for Acute Ischemic Stroke
- Alert Automated Insulin Delivery Tech Okayed for Type 2 Diabetes
- Alert FDA OKs First Adaptive DBS System for Parkinson’s Disease
- Alert FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
- Alert FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumors
- Alert FDA Approves BV+R2 Combo for R/R LBCL
- Alert FDA Approves Mirdametinib for Neurofibromatosis Type 1
- Alert FDA Approves Third Tocilizumab Biosimilar